November 6, 2017 05:17 PM ESTUpdated November 6, 09:17 PM

Japanese CMO Fujifilm Diosynth spends extra $28M in US, UK mAb facilities

Amber Tong

Fujifilm Diosynth Biotechnologies is channeling another $28 million from its parents company into two new manufacturing facilities in Texas and the UK, aggressively adding …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Japanese CMO Fujifilm Diosynth spends extra $28M in US, UK mAb facilities

Amber Tong

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Exclusive: Influential Democrat will oppose Biosecure Act ahead of House vote

Astellas CEO talks future beyond Xtandi as Japanese drugmaker puts roots in Boston

BridgeBio sticks to script for ATTR-CM as Alnylam cleans up ‘typo’ snafu

Roche's Spark loses CEO to RNA upstart; Ex-Elevation Oncology chief takes over at Affimed

Lilly inks obesity deal with seed-stage RNA startup as its genetic medicines effort enters the spotlight

How to secure full enrollment and a 30x ROI: A conversation with the CEO of the boutique enrollment agency doing just ...

Japan­ese CMO Fu­ji­film Diosynth spends ex­tra $28M in US, UK mAb fa­cil­i­ties

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Japanese CMO Fujifilm Diosynth spends extra $28M in US, UK mAb facilities